Abstract:OBJECTIVE:To investigate the clinical characteristics and therapeutic effect in the early stage of patients with Severe Acute Respiratory Syndrome (SARS).METHODS:A total of 45 clinical diagnosed SARS patients were enrolled in the study.RESULTS:43 (95.6%) of all 45 patients had exposure to SARS patients and the average incubation time was (7.3 +/- 4.7) days (range 2 to 20 days). The clinical features including fatigue (60%), dry cough (68.9%), dyspnea (53.3%), joint pain (26.7%) and diarrhea (26.7%). The laboratory test show that 33% patients with leukopenia and thrombocytopenia, 53.3% with elevated serum aminotransferase and 26.6% with increased creatinine kinase levels. The occurrence of abnormal chest radiographs was (4.2 +/- 2.9) days from the onset, and CT scanning was better than X-ray in the early diagnosis. The average time for the progression and improvement of the chest radiographs were (9.3 +/- 4.1) and (14.5 +/- 5.0) days, respectively. The administration of corticosteroids was started (4.8 +/- 3.5) days from the onset and the maximal dosage using of steroids was (8.4 +/- 3.9) days. There was a significant difference in the dosage of steroid between severe and mild patients [(610.6 +/- 212.4) mg/day vs (268.1 +/- 202.5) mg/day, P < 0.001)]. The IgG antibody was detected in 22 out of 34 (64.7%) patients and the average time for the occurrence of antibody was (18.2 +/- 6.4) days (range 9-27 days).CONCLUSION:Exposure to the SARS patients happened in most patients. The most common clinical features were fever and fatigue. The most common laboratory abnormalities were leukopenia and thrombocytopenia. Serum antibody was not detected until on the 9th day of the course of illness; CT is a more sensitive method for detection of the abnormal chest radiographs than regular X-ray test. The early usage of cortiscosteroids was an efficient method for the treatment, and the dosage of steroids should be individualized.

Symptom Combinations Associated with Outcome and Therapeutic Effects in a Cohort of Cases with SARS.

Combined Clinical and Imaging Features Better Predict the Critical Outcomes of Patients with SARS-COV-2.

Effect of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Severe Acute Respiratory Syndrome: A Meta-Analysis

Effects of Different Therapeutic Schedules on Patients with COVID-19: A Prospective Case–Control Study in China

[The Clinical Characteristics and Outcome of 45 Early Stage Patients with SARS].

Pooled-analysis on Clinical Features of Human Infection with Severe Acute Respiratory Syndrome

[Clinical Study on Treatment of Severe Acute Respiratory Syndrome by Integrative Chinese and Western Medicine].

Clinical Analysis of 120 Cases of Patients with Severe Acute Respiratory Syndrome

[Discussion about treatment of severe acute respiratory syndrome based on syndrome differentiation]

Clinical Diagnostic Approach To Severe Acute Respiratory Syndrome: An Institution'S Experience

Effects of Integrative Chinese and Western Medicine on Arterial Oxygen Saturation in Patients with Severe Acute Respiratory Syndrome

Analysis of Severe Acute Respiratory Syndrome in Beijing

Chinese Herbal Medicine for Severe Acute Respiratory Syndrome: a Systematic Review and Meta-Analysis.

Clinical investigation of outbreak of nosocomial severe acute respiratory syndrome]

The Follow-up Study on the Health Status of Convalescent Patients Recovered from SARS in Tianjin

Clinical Features of Probable Severe Acute Respiratory Syndrome in Beijing.

[The Clinical Characteristics and Staging of Severe Acute Respiratory Syndrome].

Clinical characteristics, dynamic imaging changes, treatment and outcome of severe acute respiratory syndrome in Shanghai area

[Clinical Observation on Treatment of SARS with Combination of Chaihu Droplet Pill and Huoxiang Zhengqi Droplet Pill].

[The Early Warning Signs of Deterioration of Severe Acute Respiratory Syndrome].

SARS: Prognosis, Outcome and Sequelae